Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilman D Rachner

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Ebiomedicine|December 3, 2015
RANKL/OPG in Breast Cancer - Extending Its Territory to BRCA Mutation CarriersTilman D Rachner, Martina Rauner
Lancet (London, England)|July 7, 2015
More DATA to guide sequential osteoporosis therapyLorenz C Hofbauer, Tilman D Rachner
Trends in Endocrinology and Metabolism: TEM|May 12, 2023
Cancer cachexia as a blueprint for treating obesityNikolai P Jaschke, Tilman D Rachner
The Lancet. Diabetes & Endocrinology|December 13, 2022
Long-term bone health in childhood cancer survivors: underappreciated and undertreated?Cornelia S Link-Rachner, Tilman D Rachner
Trends in Endocrinology and Metabolism: TEM|May 17, 2021
Stress-induced muscle-to-CNS signalingNikolai P Jaschke, Sophie Paehlig, Tilman D Rachner
Pharmacology & Therapeutics|March 10, 2012
Novel therapies in benign and malignant bone diseasesTilman D Rachner, Peyman Hadji, Lorenz C Hofbauer
The New England Journal of Medicine|June 29, 2018
Apalutamide and Metastasis-free Survival in Prostate CancerTilman D Rachner, Elena Tsourdi, Lorenz C Hofbauer
The New England Journal of Medicine|December 14, 2016
Bone Formation and the Wnt Signaling PathwayMartina Rauner, Tilman D Rachner, Lorenz C Hofbauer
Lancet (London, England)|April 1, 2011
Osteoporosis: now and the futureTilman D Rachner, Sundeep Khosla, Lorenz C Hofbauer
Breast Cancer Research : BCR|June 4, 2011
From bone to breast and back - the bone cytokine RANKL and breast cancerLorenz C Hofbauer, Tilman D Rachner, Christine Hamann
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Ebiomedicine|December 3, 2015
RANKL/OPG in Breast Cancer - Extending Its Territory to BRCA Mutation CarriersTilman D Rachner, Martina Rauner
Lancet (London, England)|July 7, 2015
More DATA to guide sequential osteoporosis therapyLorenz C Hofbauer, Tilman D Rachner
Trends in Endocrinology and Metabolism: TEM|May 12, 2023
Cancer cachexia as a blueprint for treating obesityNikolai P Jaschke, Tilman D Rachner
The Lancet. Diabetes & Endocrinology|December 13, 2022
Long-term bone health in childhood cancer survivors: underappreciated and undertreated?Cornelia S Link-Rachner, Tilman D Rachner
Trends in Endocrinology and Metabolism: TEM|May 17, 2021
Stress-induced muscle-to-CNS signalingNikolai P Jaschke, Sophie Paehlig, Tilman D Rachner
Pharmacology & Therapeutics|March 10, 2012
Novel therapies in benign and malignant bone diseasesTilman D Rachner, Peyman Hadji, Lorenz C Hofbauer
The New England Journal of Medicine|June 29, 2018
Apalutamide and Metastasis-free Survival in Prostate CancerTilman D Rachner, Elena Tsourdi, Lorenz C Hofbauer
The New England Journal of Medicine|December 14, 2016
Bone Formation and the Wnt Signaling PathwayMartina Rauner, Tilman D Rachner, Lorenz C Hofbauer
Lancet (London, England)|April 1, 2011
Osteoporosis: now and the futureTilman D Rachner, Sundeep Khosla, Lorenz C Hofbauer
Breast Cancer Research : BCR|June 4, 2011
From bone to breast and back - the bone cytokine RANKL and breast cancerLorenz C Hofbauer, Tilman D Rachner, Christine Hamann
Pageof 9